Known knowns and known unknowns: Risks associated with combination antithrombotic therapy

Thrombosis Research

Volumn 123, Issue SUPPL. 1, 2008, Pages S7-

  Johnson, S ^a  

^a Rock Creek Medical Center   (United States)

Author keywords

Anticoagulation; Antiplatelet; Aspirin; Pharmacy; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; WARFARIN; XIMELAGATRAN;

ANTICOAGULANT THERAPY; ARTERY DISEASE; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSENSUS DEVELOPMENT; ELECTRONIC MEDICAL RECORD; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; MONOTHERAPY; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STROKE; THROMBOSIS;

EID: 55249100477     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.08.011     Document Type: Article

References (20)

1. Wysowski D.K., Nourjah P., and Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 167 13 (2007) 1414-1419
2. Johnson S.G., Witt D.M., Eddy T.R., and Delate T. Warfarin and antiplatelet combination use among commercially insured patients enrolled in an anticoagulation management service. Chest 131 (2007) 1500-1507
3. Fanikos J., Grasso-Correnti N., Shah R., Kucher N., and Goldhaber S.Z. Major bleeding complications in a specialized anticoagulation service. Am J Cardiol 96 4 (2005) 595-598
4. Larson R.J., and Fisher E.S. Should aspirin be continued in patients started on warfarin: a systematic review and meta-analysis. J Gen Intern Med 19 (2004) 879-886
5. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey Jr. D.E., et al. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. Circulation 50 (2007) e90-e92
6. Harrington R.A., Becker R.C., Ezekowitz M., Meade T.W., O'Connor C.M., Vorchheimer D.A., et al. Antithrombotic therapy for coronary artery disease. Chest 126 (2004) 513S-548S
7. Aspirin therapy in diabetes. Diabetes Care 27 supp 1 (2004) S72-S73
8. Andreotti F., Testa L., Biondi-Zoccai G.G., and Crea F. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients. Eur Heart J 27 5 (2006) 519-526
9. Salem D.N., Stein P.D., Al-Ahmad A., Bussey H.I., Horstkotte D., Miller N., et al. Antithrombotic therapy in valvular heart disease: native and prosthetic. Chest 126 (2004) 457S-482S
10. Eikelboom J.W., and Hirsh J. Combined antiplatelet and anticoagulant therapy: clinical benefits and risks. J Thromb Haemost 5 Suppl 1 (2007 Jul) 255-263
11. SPAF Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation. Lancet 348 (1996) 633-638
12. Lechat P., Lardoux H., Mallet A., Sanchez P., Derumeaux G., Lecompte T., et al. Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation: a randomized trial. Cerebrovasc Dis 12 (2001) 245-252
13. Dimarco J.P., Flaker G., Waldo A.L., Corley S.D., Greene H.L., Safford R.E., et al. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 149 4 (2005) 645-649
14. Flaker J.C., Gruber M., Connolly S.J., Goldman S., Chaparro S., Vahanian A., et al. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Am Heart J 152 5 (2006) 967-973
15. Hylek E.M., Evans-Molina C., Shea C., Henault L.E., and Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115 (2007) 2689-2696
16. Anand S., Yusuf S., Xie C., Pogue J., Eikelboom J., Budaj A., et al. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med 357 3 (2007 19) 217-227
17. Witt D.M., Sadler M.A., Shanahan R.L., Mazzoli G., and Tillman D.J. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest 127 (2005) 1515-1522
18. Shireman T.I., Howard P.A., Kresowik T.F., and Ellerbeck E.F. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke 35 (2004) 2362-2367
19. Buresly K., Eisenberg M.J., Zhang X., and Pilote L. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med 165 (2005) 784-789
20. Johnson S.G., Rogers K.R., Delate T., and Witt D.M. Outcomes associated with combined antiplatelet and anticoagulant therapy. Chest 133 (2008) 948-954